Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 71 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Mantzoros, Christos S [Clear All Filters]
(2024).
Association of activins, follistatins and inhibins with incident hip fracture in women with postmenopausal osteoporosis: a proof of concept, case-control study..
Endocrine. 81(3), 573-578.
(2023). Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease..
Ther Clin Risk Manag. 19, 77-96.
(2023). Fibrosis-4 index predicts long-term all-cause, cardiovascular and liver-related mortality in the adult Korean population..
Clin Gastroenterol Hepatol.
(2023). Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive steatotic liver disease indexes: Results from a large multi-center study..
Metabolism. 147, 155666.
(2023). Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease..
Metabolism. 147, 155676.
(2023). Sarcopenia: still in relative definition-penia and severe treatment-penia..
Metabolism. 155717.
(2023). Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control study..
Metabolism. 141, 155397.
(2022). Dose-related meta-analysis for Omega-3 fatty acids supplementation on major adverse cardiovascular events..
Clin Nutr. 41(4), 923-930.
(2022). Metabolism, Clinical and Experimental: seventy years young and growing..
Metabolism. 155333.
(2022). Metreleptin for the treatment of lipodystrophy: leading the way among novel therapeutics for this unmet clinical need..
Curr Med Res Opin. 38(6), 885-888.
(2022).
(2022). Addressing the epidemic of fatty liver disease: A call to action, a call to collaboration, a call to moving the field forward..
Metabolism. 122, 154781.
(2021). Diabetes mellitus: 100 years since the discovery of insulin..
Metabolism. 118, 154737.
(2021).
(2021).
(2021). Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name..
Metabolism. 113, 154413.
(2020). Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis..
Metabolism. 154203.
(2020). The effect of excess body fat on female and male reproduction..
Metabolism. 154193.
(2020). The effect of underweight on female and male reproduction..
Metabolism. 107, 154229.
(2020). Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD)..
Metabolism. 154318.
(2020). Obeticholic acid for the treatment of nonalcoholic steatohepatitis: Expectations and concerns..
Metabolism. 104, 154144.
(2020). Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement..
Metabolism. 96, 66-82.
(2019). Free Cortisol Is a More Accurate Marker for Adrenal Function and Does Not Correlate with Renal Function in Cirrhosis..
Dig Dis Sci. 64(6), 1686-1694.
(2019).
(2019).